infect
urgent
develop
novel
candid
tgev
entri
bacillu
subtili
probiot
excel
antimicroorgan
properti
one
secret
surfactin
regard
versatil
weapon
plant
pathogen
especi
envelop
viru
demonstr
first
time
b
subtili
surfactin
effect
inhibit
one
anim
coronaviru
tgev
enter
intestin
porcin
epitheli
cell
line
sever
differ
experi
perform
seek
might
mechan
plaqu
assay
show
surfact
could
reduc
plaqu
gener
tgev
dosedepend
manner
meanwhil
incub
tgev
h
b
subtili
could
attach
tgev
particl
surfac
number
viru
bind
host
cell
declin
furthermor
data
show
inhibit
b
subtili
close
relat
competit
tgev
viral
entri
receptor
includ
epiderm
growth
factor
receptor
egfr
aminopeptidas
n
apn
protein
addit
western
blot
apoptosi
analysi
indic
b
subtili
could
enhanc
resist
cell
upregul
express
tolllik
receptor
tlr
reduc
percentag
apoptot
cell
taken
togeth
result
suggest
b
subtili
surfactin
antagon
tgev
entri
vitro
may
serv
promis
new
candid
tgev
prevent
found
treat
surfactin
h
percentag
apoptot
cell
depress
indict
safe
dose
safe
time
surfactin
could
display
posit
effect
cell
surfactin
affect
cell
especi
anim
cell
need
penetr
studi
result
present
studi
demonstr
b
subtili
surfactin
antivir
activ
tgev
enter
cell
possibl
overlap
mechan
lead
antivir
activ
might
compet
tgev
combin
receptor
adsorpt
trap
inactiv
viru
particl
surfactin
improv
cell
state
activ
innat
immun
induc
apoptosi
level
find
suggest
b
subtili
surfactin
could
serv
potenti
candid
tgev
entri
vitro
transmiss
gastroenter
tge
viru
tgev
envelop
viru
belong
coronavirida
famili
within
coronaviru
genu
caus
agent
porcin
tge
lead
vomit
acut
diarrhoea
dehydr
nearli
mortal
suckl
piglet
current
vaccin
neither
inactiv
attenu
provid
full
protect
pig
therefor
urgent
discov
develop
novel
antitgev
candid
reduc
econom
loss
caus
tge
surfactin
cyclic
lipopeptid
antibiot
biosurfact
synthes
bacillu
subtili
consist
anion
sevenmemb
peptid
cyclo
mixtur
sever
hydrophob
fatti
acid
chain
length
carbon
atom
amphiphil
structur
surfactin
one
strongest
biosurfact
studi
surfactin
focus
properti
phytopathogen
microorgan
antibacteri
antifung
inhibit
fibr
clot
format
antivir
abil
report
show
surfactin
could
inactiv
variou
envelop
viru
like
vesicular
stomat
viru
vsv
rhabdovirida
suid
herp
viru
type
pseudorabi
viru
insert
outer
layer
lipid
membran
bilay
envelop
disintegr
whether
surfactin
activ
tgev
anim
envelop
viru
coronavirida
famili
remain
poorli
understood
moreov
colleagu
report
b
subtili
could
antagon
enteropathogen
escherichia
coli
etec
infect
present
studi
investig
antivir
effect
b
subtili
surfactin
tgev
entri
intestin
porcin
epitheli
cell
line
cell
explor
possibl
mechan
effect
b
subtili
surfactin
viral
infect
well
impact
receptor
tgev
epiderm
growth
factor
receptor
egfr
aminopeptidas
n
apn
investig
addit
tolllik
receptor
tlr
apoptosi
cell
also
detect
result
reveal
b
subtili
surfactin
exhibit
suppress
activ
tgev
entri
may
possibl
serv
potenti
candid
reduc
econom
loss
caus
tge
cell
line
guangzhou
jennio
biotech
co
ltd
china
maintain
dulbecco
modifi
eagl
medium
nutrient
dmem
life
technolog
shanghai
china
supplement
fb
gibco
penicillinstreptomycin
life
technolog
mm
hepe
life
technolog
c
co
incub
tgev
strain
shxb
plaqu
form
unit
pfu
per
ml
pfuml
kindli
provid
jiangsu
academi
agricultur
scienc
infect
perform
multipl
infect
moi
b
subtili
donat
prof
xuewen
gao
colleg
plant
protect
nanj
agricultur
univers
cultiv
luria
broth
lb
centrifug
bacteria
wash
three
time
remov
excess
lb
final
viabl
b
subtili
resuspend
dmem
design
concentr
coloni
form
unit
cfu
per
ml
cfuml
b
subtili
surfactin
produc
transform
b
subtili
surfactin
use
present
studi
extract
b
subtili
accord
procedur
xuewen
et
al
concentr
surfactin
detect
hplc
toxic
effect
b
subtili
surfactin
cell
determin
use
mtt
viabil
assay
suspens
contain
differ
amount
b
subtili
rang
cfuml
concentr
surfactin
rang
mgml
ad
cell
monolay
plate
corn
costar
h
wash
away
mtt
mgml
sigma
ad
cell
per
well
incub
h
c
reaction
stop
ad
equal
volum
lysi
buffer
dmso
sd
ph
absorb
read
nm
cell
surviv
rate
determin
stimulatori
index
si
calcul
accord
follow
equat
si
od
infect
well
od
bank
control
od
neg
well
od
bank
well
mocktreat
cell
serv
control
experi
perform
triplic
three
setup
focus
suppress
effect
tgev
entri
vari
treatment
period
briefli
monolay
cell
treat
b
subtili
surfactin
h
respect
wash
away
infect
tgev
h
pretreat
assay
tgev
ad
cell
layer
togeth
b
subtili
surfactin
respect
h
infect
period
cotreat
assay
viru
mix
b
subtili
surfactin
respect
incub
h
c
aliquot
remov
dilut
dmem
supplement
fb
stop
effect
surfactin
steril
filter
filter
filtrat
ad
cell
layer
incub
h
outtreat
assay
indic
time
point
cell
wash
three
time
kept
medium
contain
penicillinstreptomycin
h
kill
viabl
bacteria
left
incub
cell
wash
three
time
resuspend
trizol
sigma
store
c
analys
western
blot
nuclear
cytoplasm
protein
extract
isol
use
nuclear
cytoplasm
protein
extract
kit
beyotim
jiangsu
china
assess
direct
effect
b
subtili
surfactin
tgev
perform
plaqu
format
assay
briefli
viru
mix
differ
concentr
b
subtili
surfactin
incub
h
c
exorc
surfactin
effect
probiot
describ
two
hundr
fifti
microlitr
filtrat
ad
confluent
monolay
st
cell
suscept
cell
grown
sixwel
tissu
cultur
plate
per
well
incub
h
c
wash
cell
overlaid
medium
contain
seaplagu
agaros
fb
penicillinstreptomycin
plate
incub
c
min
solidifi
overlay
medium
cell
grown
c
co
allow
plaqu
format
viral
plaqu
visual
stain
wv
crystal
violet
dye
incub
viru
titr
calcul
accord
follow
formula
titr
pfuml
number
plaquesvolum
dilut
viru
ad
well
dilut
factor
viru
use
infect
well
plaqu
enumer
viru
without
treatment
serv
control
st
cell
without
addit
tgev
serv
mock
studi
report
probiot
bacteria
might
also
indirectli
interfer
viru
alter
state
cell
stimul
innat
adapt
immun
find
b
subtili
surfactin
treatment
mediat
state
cell
made
singletreat
assay
cell
treat
cfuml
b
subtili
mgml
surfactin
h
pegfr
apn
protein
detect
western
blot
quantit
revers
transcriptionpcr
qrtpcr
total
rna
cell
extract
use
trizol
reagent
life
technolog
subject
revers
transcript
prime
script
qrtpcr
kit
takara
dalian
ca
qpcr
reaction
perform
abi
instrument
appli
biosystem
usa
gene
express
calcul
compar
c
method
normal
endogen
level
gapdh
primer
sequenc
use
qrtpcr
list
tabl
data
analys
use
abi
prism
softwar
tool
appli
biosystem
immunodetect
tgevn
pegfr
apn
protein
western
blot
rabbit
antitgev
vmrd
hangzhou
china
rabbit
antipegfr
cst
rabbit
bioss
follow
hrpconjug
goat
antimous
igg
hrpconjug
goat
antirabbit
igg
sigma
use
signal
detect
use
super
signal
west
pico
lit
thermo
scientif
subject
imag
reader
imag
system
fujifilm
japan
intens
band
term
densiti
measur
normal
gapdh
express
three
independ
experi
appropri
gel
exposur
yield
similar
result
treatment
modal
indic
time
three
differ
treatment
assay
pre
co
outtreat
assay
cell
apoptosi
analys
fitc
annexin
vpropidium
iodid
pi
stain
assay
miltenyi
biotec
shanghai
china
describ
recent
result
express
mean
sd
sem
oneway
anova
student
test
employ
determin
statist
differ
among
multipl
group
p
valu
consid
signific
p
p
necessari
ensur
dose
ad
cell
nontox
shown
figur
b
subtili
nontox
use
dose
b
subtili
nontox
cfuml
safe
dose
surfactin
mgml
therefor
safe
dose
b
subtili
cfuml
surfactin
mgml
use
next
studi
differ
treatment
detect
level
tgevn
mrna
protein
express
first
differ
drug
result
show
rel
amount
viral
rna
surfactintr
cell
decreas
treatment
side
reduc
rel
amount
viral
rna
pretreat
cotreat
cell
exist
b
subtili
could
decreas
rel
amount
viral
rna
pretreat
figur
second
differ
drug
treatment
b
subtili
show
best
suppress
activ
pretreat
enough
time
interact
cell
howev
outtreat
cell
present
b
subtili
show
signific
inhibit
surfactin
similar
result
obtain
western
blot
analysi
figur
taken
togeth
data
indic
might
hidden
associ
b
subtili
cell
surfactin
might
function
viru
cell
b
subtili
surfactin
might
show
synerget
effect
extent
detect
whether
surfactin
could
directli
reduc
infect
tgev
plaqu
assay
perform
result
show
signific
p
reduct
tgev
load
treat
mgml
surfactin
b
subtili
figur
subsequ
inhibitori
effect
surfactin
examin
mix
tgev
differ
dose
surfactin
result
show
reduct
dosedepend
manner
figur
cellfre
assay
perform
survey
attach
tgev
b
subtili
shown
figur
viru
particl
bound
b
subtili
mix
tgev
moi
b
subtili
could
attach
much
viru
bind
cellular
receptor
first
step
cov
entri
process
test
whether
drug
could
attach
viralentri
receptor
perform
singletreat
experi
interestingli
result
show
stimul
b
subtili
express
apn
protein
figur
pegfr
figur
increas
similar
effect
tgev
treatment
howev
surfactin
stimulu
chang
two
receptor
express
state
cell
import
resist
pathogen
data
shown
figur
stimul
b
subtili
could
significantli
upregul
mrna
express
cell
figur
could
demonstr
western
blot
protein
level
figur
explor
protect
effect
b
subtili
surfactin
apoptosi
cell
assess
shown
figur
tgev
could
increas
apoptosi
level
cell
extent
b
subtili
surfactin
could
significantli
reduc
apoptot
cell
number
p
although
drug
display
effect
cotreat
reduct
extent
less
singl
treatment
own
phonmenon
apoptosi
caus
tgev
mean
tgev
exist
apoptosi
level
higher
reduct
extent
apoptpsi
drug
caus
eas
tgev
enter
epitheli
cell
bind
cellular
receptor
mediat
membran
fusion
plasma
membran
endosom
uptak
previou
studi
proven
apn
protein
receptor
tgev
recent
hu
et
al
determin
egfr
anoth
receptor
tgev
enter
cell
order
interrupt
tgev
infect
origin
stage
detect
inhibit
effect
b
subtili
surfactin
tgev
entri
process
vitro
differ
experiment
protocol
appli
present
studi
pre
coand
outtreat
assay
cell
challeng
tgev
moi
close
reflect
natur
infect
result
show
surfactin
could
reduc
viru
yield
process
matter
whether
host
cell
exist
b
subtili
antivir
activ
cell
exist
figur
conjectur
surfactin
could
affect
viru
cell
b
subtili
might
alter
state
cell
eventu
lead
antivir
respons
hypothesi
confirm
sequenti
analysi
mani
report
show
probiot
could
trap
viru
drop
viru
titr
result
consist
observ
incub
differ
titr
tgev
b
subtili
could
trap
tgev
surfac
figur
interest
phenomenon
attach
abil
b
subtili
better
b
subtili
much
viru
b
subtili
surfac
mix
tgev
moi
might
indic
surfactin
secret
b
subtili
destroy
trap
virion
could
detect
western
blot
hypothesi
confirm
plaqu
assay
also
confirm
inact
surfactin
dose
depend
figur
similar
result
observ
previou
studi
use
em
dirk
vollenbroich
et
al
detect
lipid
membran
disintegr
incub
surfactin
c
h
kracht
et
al
also
report
surfactin
could
inactiv
vsv
evid
shown
probiot
could
block
viral
attach
competit
inhibit
abl
bind
viral
receptor
surfac
cell
basbaum
et
al
demonstr
gramposit
bacteria
could
activ
egfr
lipoteicho
acid
similarli
present
studi
found
stimul
b
subtili
h
phosphoryl
egfr
express
apn
protein
increas
figur
indic
b
subtili
might
compet
tgev
bind
receptor
surfac
cell
state
cell
critic
keep
healthi
includ
respons
abil
balanc
intestin
cell
prolifer
apoptosi
tlr
play
import
role
sens
virus
initi
antivir
hostdef
respons
sinc
studi
focus
tgev
entri
process
tlr
cell
surfac
investig
knowledg
cell
express
express
cell
surfac
regret
detect
cell
result
shown
surprisingli
result
show
express
upregul
incub
b
subtili
figur
result
support
fact
tlr
could
identifi
lipoprotein
gramposit
bacteria
report
novel
member
tlr
takeuchi
et
al
consist
signal
pathway
inflammasom
pathway
sever
clinic
studi
demonstr
tgev
could
induc
apoptosi
kind
cell
like
porcin
kidney
cell
st
cell
addit
studi
report
apoptosi
import
regulatori
mechan
intestin
matur
present
studi
shorttim
incub
three
treatment
could
depress
percentag
apoptot
cell
figur
depress
percentag
apoptot
cell
better
singl
treatment
tgev
exist
might
indic
tgev
could
induc
apoptosi
cell
extent
interestingli
kim
et
al
determin
surfactin
could
induc
proapoptot
lovo
cell
human
colon
carcinoma
cell
line
treat
h
studi
